Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
10 "Vascular endothelial growth factor"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
Complications
Pathophysiology of Diabetic Retinopathy: The Old and the New
Sentaro Kusuhara, Yoko Fukushima, Shuntaro Ogura, Naomi Inoue, Akiyoshi Uemura
Diabetes Metab J. 2018;42(5):364-376.   Published online October 22, 2018
DOI: https://doi.org/10.4093/dmj.2018.0182
  • 13,539 View
  • 472 Download
  • 114 Web of Science
  • 108 Crossref
AbstractAbstract PDFPubReader   

Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—including hyperpermeability, hypoperfusion, and neoangiogenesis—that eventually lead to anatomical and functional alterations in retinal neurons and glial cells. Recent advances in retinal imaging systems using optical coherence tomography technologies and pharmacological treatments using anti-vascular endothelial growth factor drugs and corticosteroids have revolutionized the clinical management of DR. However, the cellular and molecular mechanisms underlying the pathophysiology of DR are not fully determined, largely because hyperglycemic animal models only reproduce limited aspects of subclinical and early DR. Conversely, non-diabetic mouse models that represent the hallmark vascular disorders in DR, such as pericyte deficiency and retinal ischemia, have provided clues toward an understanding of the sequential events that are responsible for vision-impairing conditions. In this review, we summarize the clinical manifestations and treatment modalities of DR, discuss current and emerging concepts with regard to the pathophysiology of DR, and introduce perspectives on the development of new drugs, emphasizing the breakdown of the blood-retina barrier and retinal neovascularization.

Citations

Citations to this article as recorded by  
  • Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management
    Arpon Biswas, Abhijit Deb Choudhury, Sristi Agrawal, Amol Chhatrapati Bisen, Sachin Nashik Sanap, Sarvesh Kumar Verma, Mukesh Kumar, Anjali Mishra, Shivansh Kumar, Mridula Chauhan, Rabi Sankar Bhatta
    Journal of Ocular Pharmacology and Therapeutics.2024; 40(1): 13.     CrossRef
  • GMFB/AKT/TGF‐β3 in Müller cells mediated early retinal degeneration in a streptozotocin‐induced rat diabetes model
    Tong Zhu, Yingao Li, Lilin Zhu, Jinyuan Xu, Zijun Feng, Hao Chen, Si Shi, Caiying Liu, Qingjian Ou, Furong Gao, Jieping Zhang, Caixia Jin, Jingying Xu, Jiao Li, Jingfa Zhang, Yanlong Bi, Guo‐tong Xu, Juan Wang, Haibin Tian, Lixia Lu
    Glia.2024; 72(3): 504.     CrossRef
  • The significance of glutaredoxins for diabetes mellitus and its complications
    Mengmeng Zhou, Eva-Maria Hanschmann, Axel Römer, Thomas Linn, Sebastian Friedrich Petry
    Redox Biology.2024; 71: 103043.     CrossRef
  • Proteomic analysis of diabetic retinopathy identifies potential plasma-protein biomarkers for diagnosis and prognosis
    Bent Honoré, Javad Nouri Hajari, Tobias Torp Pedersen, Tomas Ilginis, Hajer Ahmad Al-Abaiji, Claes Sepstrup Lønkvist, Jon Peiter Saunte, Dorte Aalund Olsen, Ivan Brandslund, Henrik Vorum, Carina Slidsborg
    Clinical Chemistry and Laboratory Medicine (CCLM).2024;[Epub]     CrossRef
  • Next generation therapeutics for retinal neurodegenerative diseases
    Matthew B. Appell, Jahnavi Pejavar, Ashwin Pasupathy, Sri Vishnu Kiran Rompicharla, Saed Abbasi, Kiersten Malmberg, Patricia Kolodziejski, Laura M. Ensign
    Journal of Controlled Release.2024; 367: 708.     CrossRef
  • Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip
    Thomas L. Maurissen, Alena J. Spielmann, Gabriella Schellenberg, Marc Bickle, Jose Ricardo Vieira, Si Ying Lai, Georgios Pavlou, Sascha Fauser, Peter D. Westenskow, Roger D. Kamm, Héloïse Ragelle
    Nature Communications.2024;[Epub]     CrossRef
  • Emerging role of ferroptosis in diabetic retinopathy: a review
    Ruohong Wang, Suyun Rao, Zheng Zhong, Ke Xiao, Xuhui Chen, Xufang Sun
    Journal of Drug Targeting.2024; 32(4): 393.     CrossRef
  • Serum vitamin D is substantially reduced and predicts flares in diabetic retinopathy patients
    Yong Zhuang, Zihao Zhuang, Qingyan Cai, Xin Hu, Huibin Huang
    Journal of Diabetes Investigation.2024;[Epub]     CrossRef
  • Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study
    Maria Consiglia Trotta, Carlo Gesualdo, Caterina Claudia Lepre, Marina Russo, Franca Ferraraccio, Iacopo Panarese, Ernesto Marano, Paolo Grieco, Francesco Petrillo, Anca Hermenean, Francesca Simonelli, Michele D’Amico, Claudio Bucolo, Francesca Lazzara, F
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review
    Yuxia Huang, Jia Wang, Yu Wang, Wei Kuang, Mengjun Xie, Mei Zhang
    Journal of Ethnopharmacology.2023; 302: 115861.     CrossRef
  • Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases
    Fátima Milhano dos Santos, Sergio Ciordia, Joana Mesquita, João Paulo Castro de Sousa, Alberto Paradela, Cândida Teixeira Tomaz, Luís António Paulino Passarinha
    Cellular and Molecular Life Sciences.2023;[Epub]     CrossRef
  • Protective Effects of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells on Human Retinal Endothelial Cells in an In Vitro Model of Diabetic Retinopathy: Evidence for Autologous Cell Therapy
    Gabriella Lupo, Aleksandra Agafonova, Alessia Cosentino, Giovanni Giurdanella, Giuliana Mannino, Debora Lo Furno, Ivana Roberta Romano, Rosario Giuffrida, Floriana D’Angeli, Carmelina Daniela Anfuso
    International Journal of Molecular Sciences.2023; 24(2): 913.     CrossRef
  • Predictive factors for microvascular recovery after treatments for diabetic retinopathy
    Junyeop Lee, Yoon-Jeon Kim, Joo-Yong Lee, Young Hee Yoon, June-Gone Kim
    BMC Ophthalmology.2023;[Epub]     CrossRef
  • Pathophysiology and diagnosis of diabetic retinopathy: a narrative review
    Mohadese Estaji, Bita Hosseini, Saeed Bozorg-Qomi, Babak Ebrahimi
    Journal of Investigative Medicine.2023; 71(3): 265.     CrossRef
  • Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases
    Fátima M. Santos, Sergio Ciordia, Joana Mesquita, Carla Cruz, João Paulo Castro e Sousa, Luís A. Passarinha, Cândida T. Tomaz, Alberto Paradela
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Hypoxia-induced transcriptional differences in African and Asian versus European diabetic cybrids
    Andrew H. Dolinko, Marilyn Chwa, Kevin Schneider, Mithalesh K. Singh, Shari Atilano, Jie Wu, M. Cristina Kenney
    Scientific Reports.2023;[Epub]     CrossRef
  • Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy
    Bora TORUS, Hakan KORKMAZ, Kuyaş H. OZTURK, Fevziye B. ŞİRİN, Mehmet ARGUN, Sonmez ŞEVİK, Levent TÖK
    Minerva Endocrinology.2023;[Epub]     CrossRef
  • Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
    Sentaro Kusuhara, Maya Kishimoto-Kishi, Wataru Matsumiya, Akiko Miki, Hisanori Imai, Makoto Nakamura
    Medicina.2023; 59(4): 665.     CrossRef
  • L-type calcium channel blocker increases VEGF concentrations in retinal cells and human serum
    Anmol Kumar, Stefan Mutter, Erika B. Parente, Valma Harjutsalo, Raija Lithovius, Sinnakaruppan Mathavan, Markku Lehto, Timo P. Hiltunen, Kimmo K. Kontula, Per-Henrik Groop, Satyajit Mohapatra
    PLOS ONE.2023; 18(4): e0284364.     CrossRef
  • Efficacy and safety of curcumin in diabetic retinopathy: A protocol for systematic review and meta-analysis
    Liyuan Wang, Jiayu Xu, Tianyang Yu, Hanli Wang, Xiaojun Cai, He Sun, Godwin Ovenseri-Ogbomo
    PLOS ONE.2023; 18(4): e0282866.     CrossRef
  • Highly water-soluble diacetyl chrysin ameliorates diabetes-associated renal fibrosis and retinal microvascular abnormality in db/db mice
    Young-Hee Kang, Sin-Hye Park, Young Eun Sim, Moon-Sik Oh, Hong Won Suh, Jae-Yong Lee, Soon Sung Lim
    Nutrition Research and Practice.2023; 17(3): 421.     CrossRef
  • Preventive and management approach of triptonide, a diterpenoid compound against streptozotocin-induced diabetic retinopathy in Wistar rat model
    Chandramohan Govindasamy, Khalid S. Al-Numair, Jun Li, Weibai Chen, Guoqiang Wu
    Arabian Journal of Chemistry.2023; 16(9): 105034.     CrossRef
  • New Insights on Dietary Polyphenols for the Management of Oxidative Stress and Neuroinflammation in Diabetic Retinopathy
    Gustavo Bernardes Fanaro, Marcelo Rodrigues Marques, Karin da Costa Calaza, Rafael Brito, André Moreira Pessoni, Henrique Rocha Mendonça, Deborah Emanuelle de Albuquerque Lemos, José Luiz de Brito Alves, Evandro Leite de Souza, Marinaldo Pacífico Cavalcan
    Antioxidants.2023; 12(6): 1237.     CrossRef
  • Evaluation of Social Platform-Based Continuity of Care in Improving Cognitive and Prognostic Effects of Young Patients with Diabetic Retinopathy
    Guo-lan Cao, Ke-jian Chen
    Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1931.     CrossRef
  • Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
    Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li
    World Journal of Hepatology.2023; 15(6): 786.     CrossRef
  • The rs1800469 T/T and rs1800470 C/C genotypes of the TGFB1 gene confer protection against diabetic retinopathy in a Southern Brazilian population
    Aline Rodrigues Costa, Cristine Dieter, Luís Henrique Canani, Taís Silveira Assmann, Daisy Crispim
    Genetics and Molecular Biology.2023;[Epub]     CrossRef
  • Evaluation of Self-Care in Patients with Diabetic Retinopathy
    Songül BİLTEKİN, Züleyha KILIÇ, Şefika Dilek GÜVEN
    Turkish Journal of Diabetes and Obesity.2023; 7(3): 214.     CrossRef
  • Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy
    Janka Poráčová, Melinda Nagy, Marta Mydlárová Blaščáková, Mária Konečná, Vincent Sedlák, Mária Zahatňanská, Tatiana Kimáková, Hedviga Vašková, Viktória Rybárová, Mária Majherová, Ivan Uher
    Central European Journal of Public Health.2023; 31(Suppl 1): S4.     CrossRef
  • Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets
    Karanvir S. Raman, Joanne A. Matsubara
    Ocular Immunology and Inflammation.2022; 30(2): 470.     CrossRef
  • Adult-induced genetic ablation distinguishes PDGFB roles in blood-brain barrier maintenance and development
    Elisa Vazquez-Liebanas, Khayrun Nahar, Giacomo Bertuzzi, Annika Keller, Christer Betsholtz, Maarja Andaloussi Mäe
    Journal of Cerebral Blood Flow & Metabolism.2022; 42(2): 264.     CrossRef
  • Investigation on the Q-markers of Bushen Huoxue Prescriptions for DR treatment based on chemometric methods and spectrum-effect relationship
    Yueting Yu, Ziyu Zhu, Mengjun Xie, Liping Deng, Xuejun Xie, Mei Zhang
    Journal of Ethnopharmacology.2022; 285: 114800.     CrossRef
  • Corneal Confocal Microscopy in Type 1 Diabetes Mellitus: A Six-Year Longitudinal Study
    Stuti L. Misra, James A. Slater, Charles N. J. McGhee, Monika Pradhan, Geoffrey D. Braatvedt
    Translational Vision Science & Technology.2022; 11(1): 17.     CrossRef
  • Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature
    Thomas L. Maurissen, Georgios Pavlou, Colette Bichsel, Roberto Villaseñor, Roger D. Kamm, Héloïse Ragelle
    Journal of Personalized Medicine.2022; 12(2): 148.     CrossRef
  • Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice
    Fei Yao, Xinyi Jiang, Ling Qiu, Zixuan Peng, Wei Zheng, Lexi Ding, Xiaobo Xia
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Classification of macular abnormalities using a lightweight CNN-SVM framework
    Xuqian Wang, Yu Gu
    Measurement Science and Technology.2022; 33(6): 065702.     CrossRef
  • Chorioretinal Hypoxia Detection Using Lipid-Polymer Hybrid Organic Room-Temperature Phosphorescent Nanoparticles
    Yingying Zeng, Van Phuc Nguyen, Yanxiu Li, Do Hyun Kang, Yannis M. Paulus, Jinsang Kim
    ACS Applied Materials & Interfaces.2022; 14(16): 18182.     CrossRef
  • LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis
    Rong Luo, Lan Li, Fan Xiao, Jinsong Fu
    Inflammation.2022; 45(5): 1936.     CrossRef
  • Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review
    Charisse Y. J. Kuo, Rinki Murphy, Ilva D. Rupenthal, Odunayo O. Mugisho
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • The relationship between the neutrophil-to-lymphocyte ratio and diabetic retinopathy in adults from the United States: results from the National Health and nutrition examination survey
    Xiaojie He, Shanshan Qi, Xi Zhang, Jiandong Pan
    BMC Ophthalmology.2022;[Epub]     CrossRef
  • Th22 cells induce Müller cell activation via the Act1/TRAF6 pathway in diabetic retinopathy
    Yufei Wang, Hongdan Yu, Jing Li, Wenqiang Liu, Shengxue Yu, Pan Lv, Lipan Zhao, Xiaobai Wang, Zhongfu Zuo, Xuezheng Liu
    Cell and Tissue Research.2022; 390(3): 367.     CrossRef
  • Prevalence and Factors Associated with Diabetic Retinopathy among Adult Diabetes Patients in Southeast Ethiopia: A Hospital-Based Cross-Sectional Study
    Biniyam Sahiledengle, Tesfaye Assefa, Wogene Negash, Anwar Tahir, Tadele Regasa, Yohannes Tekalegn, Ayele Mamo, Zinash Teferu, Damtew Solomon, Habtamu Gezahegn, Kebebe Bekele, Demisu Zenbaba, Alelign Tasew, Fikreab Desta, Zegeye Regassa, Zegeye Feleke, Ch
    Clinical Ophthalmology.2022; Volume 16: 3527.     CrossRef
  • Diabetic Retinopathy: Are lncRNAs New Molecular Players and Targets?
    Simona Cataldi, Mariagiovanna Tramontano, Valerio Costa, Marianna Aprile, Alfredo Ciccodicola
    Antioxidants.2022; 11(10): 2021.     CrossRef
  • Diosgenin protects retinal pigment epithelial cells from inflammatory damage and oxidative stress induced by high glucose by activating AMPK/Nrf2/HO‐1 pathway
    Yang Hao, Xuefeng Gao
    Immunity, Inflammation and Disease.2022;[Epub]     CrossRef
  • Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases
    Huy Nguyen, Sung-Jin Lee, Yang Li
    Pharmaceutics.2022; 14(11): 2476.     CrossRef
  • Development and validation of a predictive risk model based on retinal geometry for an early assessment of diabetic retinopathy
    Minglan Wang, Xiyuan Zhou, Dan Ning Liu, Jieru Chen, Zheng Zheng, Saiguang Ling
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy
    Charisse Y-J. Kuo, Jack J. Maran, Emma G. Jamieson, Ilva D. Rupenthal, Rinki Murphy, Odunayo O. Mugisho
    International Journal of Molecular Sciences.2022; 23(22): 14471.     CrossRef
  • VEGF Gene Polymorphism Among Diabetes Mellitus and Diabetic Retinopathy
    Samra Anees, Saima Shareef, Muhammad Roman, Shah Jahan
    Futuristic Biotechnology.2022; : 02.     CrossRef
  • Th22 Cells Induce Müller Cells Activation Via the Act1/Traf6 Pathway in Diabetic Retinopathy
    YuFei Wang, Hongdan Yu, Jing Li, Wenqiang Liu, Shengxue Yu, Pan Lv, Lipan Zhao, Xiaobai Wang, Zhongfu Zuo, Xuezheng Liu
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Pathogenesis of diabetic macular edema: the role of pro-inflammatory and vascular factors. Aliterature review
    M.L. Kyryliuk, S.A. Suk
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(3): 180.     CrossRef
  • Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study
    Ryo Kubota, Chirag Jhaveri, John M. Koester, Jeffrey K. Gregory
    Graefe's Archive for Clinical and Experimental Ophthalmology.2021; 259(2): 369.     CrossRef
  • Transient receptor potential vanilloid 4 channel deletion regulates pathological but not developmental retinal angiogenesis
    Holly C. Cappelli, Brianna D. Guarino, Anantha K. Kanugula, Ravi K. Adapala, Vidushani Perera, Matthew A. Smith, Sailaja Paruchuri, Charles K. Thodeti
    Journal of Cellular Physiology.2021; 236(5): 3770.     CrossRef
  • Involvement of miR‐126 rs4636297 and miR‐146a rs2910164 polymorphisms in the susceptibility for diabetic retinopathy: a case–control study in a type 1 diabetes population
    Eloísa Toscan Massignam, Cristine Dieter, Felipe Mateus Pellenz, Taís Silveira Assmann, Daisy Crispim
    Acta Ophthalmologica.2021;[Epub]     CrossRef
  • Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients
    Malgorzata Mrugacz, Anna Bryl, Katarzyna Zorena
    Journal of Clinical Medicine.2021; 10(3): 458.     CrossRef
  • Factors based on optical coherence tomography correlated with vision impairment in diabetic patients
    Hiroaki Endo, Satoru Kase, Hikari Tanaka, Mitsuo Takahashi, Satoshi Katsuta, Yasuo Suzuki, Minako Fujii, Susumu Ishida, Manabu Kase
    Scientific Reports.2021;[Epub]     CrossRef
  • Class-3 semaphorins: Potent multifunctional modulators for angiogenesis-associated diseases
    Bo Jiao, Shiyang Liu, Xi Tan, Pei Lu, Danning Wang, Hui Xu
    Biomedicine & Pharmacotherapy.2021; 137: 111329.     CrossRef
  • Single-Cell Analysis of Blood-Brain Barrier Response to Pericyte Loss
    Maarja A. Mäe, Liqun He, Sofia Nordling, Elisa Vazquez-Liebanas, Khayrun Nahar, Bongnam Jung, Xidan Li, Bryan C. Tan, Juat Chin Foo, Amaury Cazenave-Gassiot, Markus R. Wenk, Yvette Zarb, Barbara Lavina, Susan E. Quaggin, Marie Jeansson, Chengua Gu, David
    Circulation Research.2021;[Epub]     CrossRef
  • VEGFR1 signaling in retinal angiogenesis and microinflammation
    Akiyoshi Uemura, Marcus Fruttiger, Patricia A. D'Amore, Sandro De Falco, Antonia M. Joussen, Florian Sennlaub, Lynne R. Brunck, Kristian T. Johnson, George N. Lambrou, Kay D. Rittenhouse, Thomas Langmann
    Progress in Retinal and Eye Research.2021; 84: 100954.     CrossRef
  • Changes in Gene Expression Profiling and Phenotype in Aged Multidrug Resistance Protein 4-Deficient Mouse Retinas
    Kyung Woo Kim, Sentaro Kusuhara, Atsuko Katsuyama-Yoshikawa, Sho Nobuyoshi, Megumi Kitamura, Sotaro Mori, Noriyuki Sotani, Kaori Ueda, Wataru Matsumiya, Akiko Miki, Takuji Kurimoto, Hisanori Imai, Makoto Nakamura
    Antioxidants.2021; 10(3): 455.     CrossRef
  • Circular RNAs: Novel target of diabetic retinopathy
    Huan-ran Zhou, Hong-yu Kuang
    Reviews in Endocrine and Metabolic Disorders.2021; 22(2): 205.     CrossRef
  • MicroRNA-431-5p encapsulated in serum extracellular vesicles as a biomarker for proliferative diabetic retinopathy
    Bo Yu, Mengran Xiao, Fuhua Yang, Jing Xiao, Hui Zhang, Lin Su, Xiaomin Zhang, Xiaorong Li
    The International Journal of Biochemistry & Cell Biology.2021; 135: 105975.     CrossRef
  • EndMT Regulation by Small RNAs in Diabetes-Associated Fibrotic Conditions: Potential Link With Oxidative Stress
    Roberta Giordo, Yusra M. A. Ahmed, Hilda Allam, Salah Abusnana, Lucia Pappalardo, Gheyath K. Nasrallah, Arduino Aleksander Mangoni, Gianfranco Pintus
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • Pharmacokinetics of genistein distribution in blood and retinas of diabetic and non-diabetic rats
    T. Hakami, M.I. Mahmoud, E. de Juan, M. Cooney
    Drug Metabolism and Pharmacokinetics.2021; 39: 100404.     CrossRef
  • Nimbolide ameliorates the streptozotocin-induced diabetic retinopathy in rats through the inhibition of TLR4/NF-κB signaling pathway
    Xiangwen Shu, Yali Hu, Chao Huang, Ning Wei
    Saudi Journal of Biological Sciences.2021; 28(8): 4255.     CrossRef
  • Basic regulatory effects and clinical value of metalloproteinase-14 and extracellular matrix metalloproteinase inducer in diabetic retinopathy
    Shuyan Li, Shiheng Lu, Lei Zhang, Shasha Liu, Lei Wang, Kai Lin, Jialun Du, Meixia Song
    Materials Express.2021; 11(6): 873.     CrossRef
  • Reduced Acrolein Detoxification in akr1a1a Zebrafish Mutants Causes Impaired Insulin Receptor Signaling and Microvascular Alterations
    Haozhe Qi, Felix Schmöhl, Xiaogang Li, Xin Qian, Christoph T. Tabler, Katrin Bennewitz, Carsten Sticht, Jakob Morgenstern, Thomas Fleming, Nadine Volk, Ingrid Hausser, Elena Heidenreich, Rüdiger Hell, Peter Paul Nawroth, Jens Kroll
    Advanced Science.2021;[Epub]     CrossRef
  • The Metaflammatory and Immunometabolic Role of Macrophages and Microglia in Diabetic Retinopathy
    Honglian Wu, Mengqi Wang, Xiaorong Li, Yan Shao
    Human Cell.2021; 34(6): 1617.     CrossRef
  • Inflammatory resolution and vascular barrier restoration after retinal ischemia reperfusion injury
    Steven F. Abcouwer, Sumathi Shanmugam, Arivalagan Muthusamy, Cheng-mao Lin, Dejuan Kong, Heather Hager, Xuwen Liu, David A. Antonetti
    Journal of Neuroinflammation.2021;[Epub]     CrossRef
  • Diferenças de mensuração de acuidade visual e velocidade de leitura para perto entre pacientes com retinopatia diabética. Repercussão entre conceitos de deficiência visual parcial e cegueira legal
    Roberta Freitas Momenté, Isabella Couto Amaral, Luiz Guilherme Coimbra de Brito, João Gabriel Volpato Ferraresi, Maria Luisa Gois da Fonsêca, Nadyr Antônia Damasceno, Luiz Claudio Santos de Souza Lima, Mauricio Bastos Pereira, Eduardo de França Damasceno
    Revista Brasileira de Oftalmologia.2021;[Epub]     CrossRef
  • Maintaining blood retinal barrier homeostasis to attenuate retinal ischemia-reperfusion injury by targeting the KEAP1/NRF2/ARE pathway with lycopene
    Hao Huang, Xielan Kuang, Xiaobo Zhu, Hao Cheng, Yuxiu Zou, Han Du, Han Tang, Linbin Zhou, Jingshu Zeng, Huijun Liu, Jianhua Yan, Chongde Long, Huangxuan Shen
    Cellular Signalling.2021; 88: 110153.     CrossRef
  • Luteolin, an aryl hydrocarbon receptor antagonist, alleviates diabetic retinopathy by regulating the NLRP/NOX4 signalling pathway: Experimental and molecular docking study
    Y. Yang, M. Zhou, H. Liu
    Physiology International.2021; 108(2): 172.     CrossRef
  • ALDH2/SIRT1 Contributes to Type 1 and Type 2 Diabetes-Induced Retinopathy through Depressing Oxidative Stress
    Mengshan He, Pan Long, Tao Chen, Kaifeng Li, Dongyu Wei, Yufei Zhang, Wenjun Wang, Yonghe Hu, Yi Ding, Aidong Wen, Daniela Ribeiro
    Oxidative Medicine and Cellular Longevity.2021; 2021: 1.     CrossRef
  • Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia
    Chui Ming Gemmy Cheung, Elizabeth Pearce, Beau Fenner, Piyali Sen, Victor Chong, Sobha Sivaprasad
    Ophthalmologica.2021; 244(5): 451.     CrossRef
  • The effect of psychotherapy on anxiety, depression, and quality of life in patients with diabetic retinopathy
    Suiping Li, Hong Liu, Xian Zhu
    Medicine.2021; 100(51): e28386.     CrossRef
  • Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy
    Lisa Toto, Federica Evangelista, Pasquale Viggiano, Emanuele Erroi, Giada D’Onofrio, Daniele Libertini, Annamaria Porreca, Rossella D’Aloisio, Parravano Mariacristina, Luca Di Antonio, Marta Di Nicola, Rodolfo Mastropasqua
    BioMed Research International.2020; 2020: 1.     CrossRef
  • microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy
    Julian Friedrich, David H. W. Steel, Reinier O. Schlingemann, Michael J. Koss, Hans-Peter Hammes, Guido Krenning, Ingeborg Klaassen
    Translational Vision Science & Technology.2020; 9(6): 16.     CrossRef
  • Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials
    Jose Javier Garcia-Medina, Elena Rubio-Velazquez, Elisa Foulquie-Moreno, Ricardo P Casaroli-Marano, Maria Dolores Pinazo-Duran, Vicente Zanon-Moreno, Monica del-Rio-Vellosillo
    Antioxidants.2020; 9(6): 561.     CrossRef
  • Methylglyoxal, a Highly Reactive Dicarbonyl Compound, in Diabetes, Its Vascular Complications, and Other Age-Related Diseases
    C. G. Schalkwijk, C. D. A. Stehouwer
    Physiological Reviews.2020; 100(1): 407.     CrossRef
  • Pericytes, inflammation, and diabetic retinopathy
    Benjamin G. Spencer, Jose J. Estevez, Ebony Liu, Jamie E. Craig, John W. Finnie
    Inflammopharmacology.2020; 28(3): 697.     CrossRef
  • Eye hemodynamic data and biochemical parameters of the lacrimal fluid of patients with non-proliferative diabetic retinopathy
    Guzal Kangilbaeva, Fazilat Bakhritdinova, Iroda Nabieva, Aziza Jurabekova
    Data in Brief.2020; 32: 106237.     CrossRef
  • Endocannabinoids in aqueous humour of patients with or without diabetes
    Patrick Richardson, Catherine Ortori, Dave Barrett, Saoirse O'Sullivan, Iskandar Idris
    BMJ Open Ophthalmology.2020; 5(1): e000425.     CrossRef
  • A pyruvate dehydrogenase kinase inhibitor prevents retinal cell death and improves energy metabolism in rat retinas after ischemia/reperfusion injury
    Kota Sato, Seiya Mochida, Daisuke Tomimoto, Takahiro Konuma, Naoki Kiyota, Satoru Tsuda, Yukihiro Shiga, Kazuko Omodaka, Toru Nakazawa
    Experimental Eye Research.2020; 193: 107997.     CrossRef
  • The Role of Bone Morphogenetic Proteins in Diabetic Complications
    Nimna Perera, Rebecca H. Ritchie, Mitchel Tate
    ACS Pharmacology & Translational Science.2020; 3(1): 11.     CrossRef
  • Increased Ephrin-B2 expression in pericytes contributes to retinal vascular death in rodents
    Maha Coucha, Amy C. Barrett, Joseph Bailey, Maryam Abdelghani, Mohammed Abdelsaid
    Vascular Pharmacology.2020; 131: 106761.     CrossRef
  • Mitochondrial Defects Drive Degenerative Retinal Diseases
    Deborah A. Ferrington, Cody R. Fisher, Renu A. Kowluru
    Trends in Molecular Medicine.2020; 26(1): 105.     CrossRef
  • Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis
    Takuya Miyagawa, Takashi Taniguchi, Ryosuke Saigusa, Maiko Fukayama, Takehiro Takahashi, Takashi Yamashita, Megumi Hirabayashi, Shunsuke Miura, Kouki Nakamura, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano
    Rheumatology.2020; 59(8): 2005.     CrossRef
  • Natriuretic Peptides Attenuate Retinal Pathological Neovascularization Via Cyclic Guanosine Monophosphate Signaling in Pericytes and Astrocytes
    Katarina Špiranec Spes, Sabrina Hupp, Franziska Werner, Franziska Koch, Katharina Völker, Lisa Krebes, Ulrike Kämmerer, Katrin G. Heinze, Barbara M. Braunger, Michaela Kuhn
    Arteriosclerosis, Thrombosis, and Vascular Biology.2020; 40(1): 159.     CrossRef
  • Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy
    Shuai Wang, Shanshan Du, Wenzhan Wang, Fengyan Zhang
    Biomedicine & Pharmacotherapy.2020; 130: 110573.     CrossRef
  • The role of CD44 in pathological angiogenesis
    Li Chen, Chenying Fu, Qing Zhang, Chengqi He, Feng Zhang, Quan Wei
    The FASEB Journal.2020; 34(10): 13125.     CrossRef
  • Associations between alcohol intake and diabetic retinopathy risk: a systematic review and meta-analysis
    Chen Chen, Zhaojun Sun, Weigang Xu, Jun Tan, Dan Li, Yiting Wu, Ting Zheng, Derong Peng
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Alpha-Smooth Muscle Actin-Positive Perivascular Cells in Diabetic Retina and Choroid
    Soo Jin Kim, Sang A. Kim, Yeong A. Choi, Do Young Park, Junyeop Lee
    International Journal of Molecular Sciences.2020; 21(6): 2158.     CrossRef
  • The G‐protein‐coupled chemoattractant receptor Fpr2 exacerbates neuroglial dysfunction and angiogenesis in diabetic retinopathy
    Ying Yu, Shengding Xue, Keqiang Chen, Yingying Le, Rongrong Zhu, Shiyi Wang, Shuang Liu, Xinliang Cheng, Huaijin Guan, Ji Ming Wang, Hui Chen
    FASEB BioAdvances.2020; 2(10): 613.     CrossRef
  • Dual-Acting Antiangiogenic Gene Therapy Reduces Inflammation and Regresses Neovascularization in Diabetic Mouse Retina
    Rute S. Araújo, Diogo B. Bitoque, Gabriela A. Silva
    Molecular Therapy - Nucleic Acids.2020; 22: 329.     CrossRef
  • The cells involved in the pathological process of diabetic retinopathy
    Songtao Yang, Jiaoyue Zhang, Lulu Chen
    Biomedicine & Pharmacotherapy.2020; 132: 110818.     CrossRef
  • The Role of Transforming Growth Factor-Beta in Retinal Ganglion Cells with Hyperglycemia and Oxidative Stress
    Hsin-Yi Chen, Yi-Jung Ho, Hsiu-Chuan Chou, En-Chi Liao, Yi-Ting Tsai, Yu-Shan Wei, Li-Hsun Lin, Meng-Wei Lin, Yi-Shiuan Wang, Mei-Lan Ko, Hong-Lin Chan
    International Journal of Molecular Sciences.2020; 21(18): 6482.     CrossRef
  • Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs
    Ashay D. Bhatwadekar, Varun Rameswara
    Expert Opinion on Investigational Drugs.2020; 29(12): 1431.     CrossRef
  • Blood-retinal barrier as a converging pivot in understanding the initiation and development of retinal diseases
    Xue Yang, Xiao-Wei Yu, Dan-Dan Zhang, Zhi-Gang Fan
    Chinese Medical Journal.2020; 133(21): 2586.     CrossRef
  • Immunosubunit β5i Knockout Suppresses Neovascularization and Restores Autophagy in Retinal Neovascularization by Targeting ATG5 for Degradation
    Liyang Ji, Li Li, Ying Zhao, Shengqiang Liu, Jingmin Li, Jinsong Zhang, Qi Zhao, Shuai Wang
    Investigative Opthalmology & Visual Science.2020; 61(14): 30.     CrossRef
  • Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study
    Yoo-Ri Chung, Kyoung Hwa Ha, Hyeon Chang Kim, Sang Jun Park, Kihwang Lee, Dae Jung Kim
    Diabetes & Metabolism Journal.2019; 43(5): 640.     CrossRef
  • Age-related changes of the human retinal vessels: Possible involvement of lipid peroxidation
    Tapas Chandra Nag, Meenakshi Maurya, Tara Sankar Roy
    Annals of Anatomy - Anatomischer Anzeiger.2019; 226: 35.     CrossRef
  • Human iPSCs-Derived Endothelial Cells with Mutation in HNF1A as a Model of Maturity-Onset Diabetes of the Young
    Kachamakova-Trojanowska, Stepniewski, Dulak
    Cells.2019; 8(11): 1440.     CrossRef
  • Diabetic Retinopathy–An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes
    Stephen H. Sinclair, Stanley S. Schwartz
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Identification of Diagnostic and Prognostic microRNAs for Recurrent Vitreous Hemorrhage in Patients with Proliferative Diabetic Retinopathy
    Parviz Mammadzada, Juliette Bayle, Johann Gudmundsson, Anders Kvanta, Helder André
    Journal of Clinical Medicine.2019; 8(12): 2217.     CrossRef
  • RANKL blockade suppresses pathological angiogenesis and vascular leakage in ischemic retinopathy
    Sangmi Ock, Soyoung Park, Junyeop Lee, Jaetaek Kim
    Biochemical and Biophysical Research Communications.2019; 516(2): 350.     CrossRef
  • EndogenousClostridium perfringensPanophthalmitis with Potential Entry Port from Diverticulitis Exacerbated by Proliferative Diabetic Retinopathy
    Vamsee Neerukonda, Anny M. S. Cheng, Swetha Dhanireddy, Samuel Alpert, Han Y. Yin
    Case Reports in Ophthalmological Medicine.2019; 2019: 1.     CrossRef
  • Attenuation of Retinal Endothelial Vasodilator Function in a Rat Model of Retinopathy of Prematurity
    Ayuki Nakano, Asami Mori, Shiho Arima, Daiki Asano, Akane Morita, Kenji Sakamoto, Tohru Nagamitsu, Tsutomu Nakahara
    Current Eye Research.2019; 44(12): 1360.     CrossRef
  • Efficacy of fenofibrate for diabetic retinopathy
    Xing-jie Su, Lin Han, Yan-Xiu Qi, Hong-wei Liu
    Medicine.2019; 98(14): e14999.     CrossRef
  • Nutraceuticals for the Treatment of Diabetic Retinopathy
    Maria Grazia Rossino, Giovanni Casini
    Nutrients.2019; 11(4): 771.     CrossRef
  • Efficacy of ranibizumab for the treatment of diabetic retinopathy
    Yong-bo Ren, Xing-jie Su, Yan-xiu Qi, He-qun Luan, Qi Sun
    Medicine.2019; 98(17): e15409.     CrossRef
Current Concepts in Diabetic Retinopathy
Su Jeong Song, Tien Yin Wong
Diabetes Metab J. 2014;38(6):416-425.   Published online December 15, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.6.416
  • 5,255 View
  • 48 Download
  • 37 Web of Science
  • 35 Crossref
AbstractAbstract PDFPubReader   

For the past several decades, tremendous efforts have been made to decrease the complications of diabetes, including diabetic retinopathy. New diagnostic modalities like ultrawide field fundus fluorescein angiography and spectral domain optical coherence tomography has allowed more accurate diagnosis of early diabetic retinopathy and diabetic macular edema. Antivascular endothelial growth factors are now extensively used to treat diabetic retinopathy and macular edema with promising results. There remains uncertainty over the long term effects and the socioeconomic costs of these agents.

Citations

Citations to this article as recorded by  
  • Ocular microvascular alteration in patients with myocardial infarction—a new OCTA study
    Jun-Yi Wu, Jin-Yu Hu, Qian-Min Ge, San-Hua Xu, Jie Zou, Min Kang, Ping Ying, Hong Wei, Qian Ling, Liang-Qi He, Cheng Chen, Yi Shao
    Scientific Reports.2024;[Epub]     CrossRef
  • Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review
    Alexandra-Ioana Dănilă, Laura Andreea Ghenciu, Emil Robert Stoicescu, Sorin Lucian Bolintineanu, Roxana Iacob, Mihai-Alexandru Săndesc, Alexandra Corina Faur
    Biomedicines.2024; 12(4): 747.     CrossRef
  • Correlation Between Thyroid-Related Hormones and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients with Normal Thyroid Function: A Retrospective Study
    Mei Xiao, Guangwen Luo, Zhaowei Zhang, Yanfen Liu, Rui Gong, Jianghuan Ke
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 1481.     CrossRef
  • Novel risk score model for non-proliferative diabetic retinopathy based on untargeted metabolomics of venous blood
    Xinyu Wang, Shu Yang, Guangyan Yang, Jialong Lin, Pengfei Zhao, Jingyun Ding, Hongyan Sun, Ting Meng, Ming Ming Yang, Lin Kang, Zhen Liang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Diabetic Retinopathy: An Overview on Mechanisms, Pathophysiology and Pharmacotherapy
    Prawej Ansari, Noushin Tabasumma, Nayla Nuren Snigdha, Nawfal Hasan Siam, Rachana V. N. R. S. Panduru, Shofiul Azam, J. M. A. Hannan, Yasser H. A. Abdel-Wahab
    Diabetology.2022; 3(1): 159.     CrossRef
  • Effect of retinol and α-tocopherol supplementation on photoreceptor and retinal ganglion cell apoptosis in diabetic rats model
    Andi Muhammad Ichsan, Agussalim Bukhari, Subehan Lallo, Upik Anderiani Miskad, Andi Afdal Dzuhry, Itzar Chaidir Islam, Habibah Setyawati Muhiddin
    International Journal of Retina and Vitreous.2022;[Epub]     CrossRef
  • Diabetic retinopathy risk prediction in patients with type 2 diabetes mellitus using a nomogram model
    Qian Wang, Ni Zeng, Hongbo Tang, Xiaoxia Yang, Qu Yao, Lin Zhang, Han Zhang, Ying Zhang, Xiaomei Nie, Xin Liao, Feng Jiang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Dietary glutamic acid and aspartic acid as biomarkers for predicting diabetic retinopathy
    So Young Park, Jieun Kim, Jung Il Son, Sang Youl Rhee, Do-Yeon Kim, Suk Chon, Hyunjung Lim, Jeong-Taek Woo
    Scientific Reports.2021;[Epub]     CrossRef
  • Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema
    Sang Youl Rhee, Eun Sung Jung, Dong Ho Suh, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo, Choong Hwan Lee
    Scientific Reports.2021;[Epub]     CrossRef
  • Dysbiosis in the Gut Microbiome in Streptozotocin-Induced Diabetes Rats and Follow-Up During Retinal Changes
    Shalem Raj Padakandla, Taraprasad Das, Gumpili Sai Prashanthi, Kiran Kumar Angadi, S. Sreenivasa Reddy, G. Bhanuprakash Reddy, Sisinthy Shivaji
    Investigative Opthalmology & Visual Science.2021; 62(10): 31.     CrossRef
  • Importance of medication adherence in treatment needed diabetic retinopathy
    Chia-Chen Kao, Hui-Min Hsieh, Daniel Yu Lee, Kun-Pin Hsieh, Shwu-Jiuan Sheu
    Scientific Reports.2021;[Epub]     CrossRef
  • Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy


    Kaleab Alemayehu Zewdie, Muluken Altaye Ayza, Bekalu Amare, Ebrahim M. Yimer
    Clinical Ophthalmology.2020; Volume 14: 1741.     CrossRef
  • Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study
    Fatemeh Moosaie, Reza Mohamadhosseinzadeh Davatgari, Fatemeh Dehghani Firouzabadi, Sadaf Esteghamati, Niloofar Deravi, Alipasha Meysamie, Pegah Khaloo, Manouchehr Nakhjavani, Alireza Esteghamati
    Canadian Journal of Diabetes.2020; 44(5): 414.     CrossRef
  • Microfluidic Immunosensor for Point-of-Care-Testing of Beta-2-Microglobulin in Tear
    Surjendu Maity, Subhradip Ghosh, Tamanna Bhuyan, Dipankar Das, Dipankar Bandyopadhyay
    ACS Sustainable Chemistry & Engineering.2020; 8(25): 9268.     CrossRef
  • Correlations of blood lipids with early changes in macular thickness in patients with diabetes
    J. Liang, W. Lei, J. Cheng
    Journal Français d'Ophtalmologie.2019; 42(3): 276.     CrossRef
  • Evaluation of microvascular changes in the perifoveal vascular network using optical coherence tomography angiography (OCTA) in type I diabetes mellitus: a large scale prospective trial
    Javier Zarranz-Ventura, Marina Barraso, Anibal Alé-Chilet, Teresa Hernandez, Cristian Oliva, Jesus Gascón, Anna Sala-Puigdollers, Marc Figueras-Roca, Irene Vinagre, Emilio Ortega, Enric Esmatjes, Alfredo Adan
    BMC Medical Imaging.2019;[Epub]     CrossRef
  • Hyperglycemia Induces Neutrophil Extracellular Traps Formation Through an NADPH Oxidase-Dependent Pathway in Diabetic Retinopathy
    Luoziyi Wang, Xin Zhou, Yizhou Yin, Yuxin Mai, Desai Wang, Xuedong Zhang
    Frontiers in Immunology.2019;[Epub]     CrossRef
  • The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes
    Jacqueline Chua, Ai-Ru Chia, Miao Li Chee, Ryan Eyn Kidd Man, Gavin Siew Wei Tan, Ecosse L. Lamoureux, Tien Yin Wong, Mary Foong-Fong Chong, Leopold Schmetterer
    Scientific Reports.2018;[Epub]     CrossRef
  • Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy
    Odunayo O. Mugisho, Ilva D. Rupenthal, David M. Squirrell, Sarah J. Bould, Helen V. Danesh-Meyer, Jie Zhang, Colin R. Green, Monica L. Acosta, Alfred S Lewin
    PLOS ONE.2018; 13(8): e0202156.     CrossRef
  • Correlation Analysis between Foveal Avascular Zone and Peripheral Ischemic Index in Diabetic Retinopathy: A Pilot Study
    Alessandro Rabiolo, Maria Vittoria Cicinelli, Eleonora Corbelli, Giovanni Baldin, Adriano Carnevali, Rosangela Lattanzio, Lea Querques, Francesco Bandello, Giuseppe Querques
    Ophthalmology Retina.2018; 2(1): 46.     CrossRef
  • Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy
    Sang Youl Rhee, Eun Sung Jung, Hye Min Park, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo, Choong Hwan Lee
    Metabolomics.2018;[Epub]     CrossRef
  • Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM
    Bora Eldem, Sengul Ozdek, Ali Osman Saatci, Emin Ozmert, Esat Ulay, Gulsah Nomak
    Journal of Ophthalmology.2017; 2017: 1.     CrossRef
  • Letter: Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data (Diabetes Metab J 2017;41:393-404)
    Jae-Seung Yun
    Diabetes & Metabolism Journal.2017; 41(6): 492.     CrossRef
  • Targeting VEGF in eye neovascularization: What's new?
    Marialaura Amadio, Stefano Govoni, Alessia Pascale
    Pharmacological Research.2016; 103: 253.     CrossRef
  • Actualización de la retinopatía diabética para médicos de atención primaria: hacia una mejora de la medicina telemática
    J.E. Muñoz de Escalona-Rojas, A. Quereda-Castañeda, O. García-García
    SEMERGEN - Medicina de Familia.2016; 42(3): 172.     CrossRef
  • Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials
    Ronald P Danis, Srinivas Sadda, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup
    British Journal of Ophthalmology.2016; 100(6): 796.     CrossRef
  • Association between LEKR1‐CCNL1 and IGSF21‐KLHDC7A gene polymorphisms and diabetic retinopathy of type 2 diabetes mellitus in the Chinese Han population
    Xiaohui Lin, Jihong Wang, Lixia Yun, Shuhong Jiang, Langen Li, Xiaohai Chen, Zhen Li, Qiang Lu, Yihui Zhang, Xiaocheng Ma
    The Journal of Gene Medicine.2016; 18(10): 282.     CrossRef
  • Current Challenges in Diabetic Retinopathy: Are We Really Doing Better?
    Jae Hyuck Lee, Su Jeong Song
    Endocrinology and Metabolism.2016; 31(2): 254.     CrossRef
  • Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat
    Marialaura Amadio, Alessia Pascale, Sarha Cupri, Rosario Pignatello, Cecilia Osera, Velia D⿿Agata, Agata Grazia D⿿Amico, Gian Marco Leggio, Barbara Ruozi, Stefano Govoni, Filippo Drago, Claudio Bucolo
    Pharmacological Research.2016; 111: 713.     CrossRef
  • Lipoprotein(a) predicts the development of diabetic retinopathy in people with type 2 diabetes mellitus
    Jae-Seung Yun, Tae-Seok Lim, Seon-Ah Cha, Yu-Bae Ahn, Ki-Ho Song, Jin A. Choi, Jinwoo Kwon, Donghyun Jee, Yang Kyung Cho, Yong-Moon Park, Seung-Hyun Ko
    Journal of Clinical Lipidology.2016; 10(2): 426.     CrossRef
  • Nanoengineering of therapeutics for retinal vascular disease
    Nivriti Gahlaut, Sandra Suarez, Md. Imam Uddin, Andrew Y. Gordon, Stephanie M. Evans, Ashwath Jayagopal
    European Journal of Pharmaceutics and Biopharmaceutics.2015; 95: 323.     CrossRef
  • Functional outcome of macular edema in different retinal disorders
    Oren Tomkins-Netzer, Filis Ismetova, Asaf Bar, Sophie Seguin-Greenstein, Michal Kramer, Sue Lightman
    Progress in Retinal and Eye Research.2015; 48: 119.     CrossRef
  • Recent developments in ocular drug delivery
    Hongming Chen
    Journal of Drug Targeting.2015; 23(7-8): 597.     CrossRef
  • Potential New Modes of Treatment of Neurotrophic Keratopathy
    Ryoji Yanai, Teruo Nishida, Tai-Ichiro Chikama, Naoyuki Morishige, Naoyuki Yamada, Koh-Hei Sonoda
    Cornea.2015; 34(Supplement): S121.     CrossRef
  • What have we learnt about the management of diabetic macular edema in the antivascular endothelial growth factor and corticosteroid era?
    Aniruddha Agarwal, Salman Sarwar, Yasir J. Sepah, Quan D. Nguyen
    Current Opinion in Ophthalmology.2015; 26(3): 177.     CrossRef
Original Articles
Comparison of EGF with VEGF Non-Viral Gene Therapy for Cutaneous Wound Healing of Streptozotocin Diabetic Mice
Junghae Ko, Haejung Jun, Hyesook Chung, Changshin Yoon, Taekyoon Kim, Minjeong Kwon, Soonhee Lee, Soojin Jung, Mikyung Kim, Jeong Hyun Park
Diabetes Metab J. 2011;35(3):226-235.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.226
  • 4,384 View
  • 34 Download
  • 20 Crossref
AbstractAbstract PDFPubReader   
Background

To accelerate the healing of diabetic wounds, various kinds of growth factors have been employed. It is the short half-life of administered growth factors in hostile wound beds that have limited wide-spread clinical usage. To overcome this limitation, growth factor gene therapy could be an attractive alternative rather than direct application of factors onto the wound beds. We administered two growth factor DNAs, epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) into a cutaneous wound on diabetic mice. We compared the different characteristics of the healing wounds.

Methods

Streptozotocin was injected intraperitoneally to induce diabetes into C57BL/6J mice. The ultrasound micro-bubble destruction method with SonoVue as a bubbling agent was used for non-viral gene delivery of EGF828 and VEGF165 DNAs. Each gene was modified for increasing efficacy as FRM-EGF828 or minicircle VEGF165. The degree of neoangiogenesis was assessed using qualitative laser Doppler flowmetry. We compared wound size and histological findings of the skin wounds in each group.

Results

In both groups, accelerated wound closure was observed in the mice receiving gene therapy compared with non treated diabetic control mice. Blood flow detected by laser doppler flowmetry was better in the VEGF group than in the EGF group. Wound healing rates and histological findings were more accelerated in the EGF gene therapy group than the VEGF group, but were not statistically significant.

Conclusion

Both non-viral EGF and VEGF gene therapy administrations could improve the speed and quality of skin wound healing. However, the detailed histological characteristics of the healing wounds were different.

Citations

Citations to this article as recorded by  
  • Gene therapy to enhance angiogenesis in chronic wounds
    Elnaz Shaabani, Maryam Sharifiaghdam, Reza Faridi-Majidi, Stefaan C. De Smedt, Kevin Braeckmans, Juan C. Fraire
    Molecular Therapy - Nucleic Acids.2022; 29: 871.     CrossRef
  • Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery
    Adam G. Berger, Jonathan J. Chou, Paula T. Hammond
    Advances in Wound Care.2021; 10(9): 503.     CrossRef
  • Limited Treatment Options for Diabetic Wounds: Barriers to Clinical Translation Despite Therapeutic Success in Murine Models
    May Barakat, Luisa A. DiPietro, Lin Chen
    Advances in Wound Care.2021; 10(8): 436.     CrossRef
  • Minicircle‐based expression of vascular endothelial growth factor in mesenchymal stromal cells from diverse human tissues
    Joana Serra, Cláudia P. A. Alves, Joaquim M. S. Cabral, Gabriel A. Monteiro, Cláudia L. da Silva, Duarte Miguel F. Prazeres
    The Journal of Gene Medicine.2021;[Epub]     CrossRef
  • Mathematical Model Predicts that Acceleration of Diabetic Wound Healing is Dependent on Spatial Distribution of VEGF-A mRNA (AZD8601)
    S. Michaela Rikard, Paul J. Myers, Joachim Almquist, Peter Gennemark, Anthony C. Bruce, Maria Wågberg, Regina Fritsche-Danielson, Kenny M. Hansson, Matthew J. Lazzara, Shayn M. Peirce
    Cellular and Molecular Bioengineering.2021; 14(4): 321.     CrossRef
  • β-Neoendorphin Enhances Wound Healing by Promoting Cell Migration in Keratinocyte
    Dong Joo Yang, Sang Hyun Moh, Yun-Hee Choi, Ki Woo Kim
    Molecules.2020; 25(20): 4640.     CrossRef
  • Orf Virus IL-10 and VEGF-E Act Synergistically to Enhance Healing of Cutaneous Wounds in Mice
    Lyn M. Wise, Gabriella S. Stuart, Nicola C. Jones, Stephen B. Fleming, Andrew A. Mercer
    Journal of Clinical Medicine.2020; 9(4): 1085.     CrossRef
  • Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor–Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy
    Joana Serra, Cláudia P.A. Alves, Liliana Brito, Gabriel A. Monteiro, Joaquim M.S. Cabral, Duarte Miguel F. Prazeres, Cláudia L. da Silva
    Human Gene Therapy.2019; 30(3): 316.     CrossRef
  • Therapeutic strategies for enhancing angiogenesis in wound healing
    Austin P. Veith, Kayla Henderson, Adrianne Spencer, Andrew D. Sligar, Aaron B. Baker
    Advanced Drug Delivery Reviews.2019; 146: 97.     CrossRef
  • Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing
    Céline M. Desmet, Véronique Préat, Bernard Gallez
    Advanced Drug Delivery Reviews.2018; 129: 262.     CrossRef
  • Electrospun Fibers as a Dressing Material for Drug and Biological Agent Delivery in Wound Healing Applications
    Mulugeta Gizaw, Jeffrey Thompson, Addison Faglie, Shih-Yu Lee, Pierre Neuenschwander, Shih-Feng Chou
    Bioengineering.2018; 5(1): 9.     CrossRef
  • Non-viral gene therapy: Gains and challenges of non-invasive administration methods
    Marianna Foldvari, Ding Wen Chen, Nafiseh Nafissi, Daniella Calderon, Lokesh Narsineni, Amirreza Rafiee
    Journal of Controlled Release.2016; 240: 165.     CrossRef
  • RETRACTED ARTICLE: Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds
    Zhengzheng Wu, Yan Tang, Hongdou Fang, Zhongchun Su, Bin Xu, Yongliang Lin, Peng Zhang, Xing Wei
    Journal of Materials Science: Materials in Medicine.2015;[Epub]     CrossRef
  • Acute and chronic wound fluids inversely influence adipose‐derived stem cell function: molecular insights into impaired wound healing
    Paola Koenen, Timo A Spanholtz, Marc Maegele, Ewa Stürmer, Thomas Brockamp, Edmund Neugebauer, Oliver C Thamm
    International Wound Journal.2015; 12(1): 10.     CrossRef
  • Adipose‐derived stem cells and keratinocytes in a chronic wound cell culture model: the role of hydroxyectoine
    Oliver C Thamm, Panagiotis Theodorou, Ewa Stuermer, Max J Zinser, Edmund A Neugebauer, Paul C Fuchs, Paola Koenen
    International Wound Journal.2015; 12(4): 387.     CrossRef
  • Genetic and cellular techniques emerge as promising modalities for the treatment of diabetic foot syndrome
    Vladimir Iosifovich Konenkov, Vadim Valerievich Klimontov
    Diabetes mellitus.2014; 17(1): 63.     CrossRef
  • Analysis of blood flow and local expression of angiogenesis-associated growth factors in infected wounds treated with negative pressure wound therapy
    CHENG-YAN XIA, AI-XI YU, BAIWEN QI, MIN ZHOU, ZONG-HUAN LI, WEI-YANG WANG
    Molecular Medicine Reports.2014; 9(5): 1749.     CrossRef
  • Alteration of Skin Properties with Autologous Dermal Fibroblasts
    Rajesh Thangapazham, Thomas Darling, Jon Meyerle
    International Journal of Molecular Sciences.2014; 15(5): 8407.     CrossRef
  • Angiopoietin-like 4 Stimulates STAT3-mediated iNOS Expression and Enhances Angiogenesis to Accelerate Wound Healing in Diabetic Mice
    Han Chung Chong, Jeremy Soon Kiat Chan, Chi Qin Goh, Natalia V Gounko, Baiwen Luo, Xiaoling Wang, Selin Foo, Marcus Thien Chong Wong, Cleo Choong, Sander Kersten, Nguan Soon Tan
    Molecular Therapy.2014; 22(9): 1593.     CrossRef
  • Genome Editing of Mouse Fibroblasts by Homologous Recombination for Sustained Secretion of PDGF-B and Augmentation of Wound Healing
    Jenny C. Barker, Adam D. Barker, Jessica Bills, Jiying Huang, Mary Wight-Carter, Imelda Delgado, Debby L. Noble, Lily J. Huang, Matthew H. Porteus, Kathryn E. Davis
    Plastic and Reconstructive Surgery.2014; 134(3): 389e.     CrossRef
Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
Mi Young Lee, Myoung Sook Shim, Bo Hwan Kim, Soon Won Hong, Ran Choi, Eun Young Lee, Soo Min Nam, Gun Woo Kim, Jang Yel Shin, Young Goo Shin, Choon Hee Chung
Diabetes Metab J. 2011;35(2):130-137.   Published online April 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.2.130
  • 3,700 View
  • 64 Download
  • 15 Crossref
AbstractAbstract PDFPubReader   
Background

While there is an evidence that the anti-inflammatory properties of spironolactone can attenuate proteinuria in type 2 diabetes, its effects on vascular endothelial growth factor (VEGF) expression in diabetic nephropathy have not been clearly defined. In this study, we examined the effects of spironolactone, losartan, and a combination of these two drugs on albuminuria, renal VEGF expression, and inflammatory and oxidative stress markers in a type 2 diabetic rat model.

Methods

Thirty-three Otsuka-Long-Evans-Tokushima-Fatty (OLETF) rats were divided into four groups and treated with different medication regimens from weeks 25 to 50; OLETF diabetic controls (n=5), spironolactone-treated (n=10), losartan-treated (n=9), and combination of spironolactone- and losartan-treated (n=9).

Results

At week 50, the albumin-to-creatinine ratio was significantly decreased in the losartan and combination groups compared to the control OLETF group. No decrease was detected in the spironolactone group. There was a significant reduction in renal VEGF, transforming growth factor (TGF)-β, and type IV collagen mRNA levels in the spironolactone- and combination regimen-treated groups. Twenty-four hour urine monocyte chemotactic protein-1 levels were comparable in all four groups but did show a decreasing trend in the losartan and combination regimen groups. Twenty-four hour urine malondialdehyde levels were significantly decreased in the spironolactone- and combination regimen-treated groups.

Conclusion

These results suggest that losartan alone and a combined regimen of spironolactone and losartan could ameliorate albuninuria by reducing renal VEGF expression. Also, simultaneous treatment with spironolactone and losartan may have protective effects against diabetic nephropathy by decreasing TGF-β and type IV collagen expression and by reducing oxidative stress in a type 2 diabetic rat model.

Citations

Citations to this article as recorded by  
  • Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury
    Mahyar Khazaeli, Ane C. F. Nunes, Yitong Zhao, Mahziar Khazaali, John Prudente, Nosratola D. Vaziri, Bhupinder Singh, Wei Ling Lau
    Pharmacology Research & Perspectives.2023;[Epub]     CrossRef
  • Type 2 Diabetes Mellitus: Pathogenic Features and Experimental Models in Rodents
    Inessa G. Gvazava, M. V. Karimova, A. V. Vasiliev, E. A. Vorotelyak
    Acta Naturae.2022; 14(3): 57.     CrossRef
  • Role of mineralocorticoid receptor antagonists in kidney diseases
    Vishal Patel, Amit Joharapurkar, Mukul Jain
    Drug Development Research.2021; 82(3): 341.     CrossRef
  • Multi-strain probiotic supplement attenuates streptozotocin-induced type-2 diabetes by reducing inflammation and β-cell death in rats
    Pei-Shan Hsieh, Hsieh-Hsun Ho, Shu Ping Tsao, Shih-Hung Hsieh, Wen-Yang Lin, Jui-Fen Chen, Yi-Wei Kuo, Shin-Yu Tsai, Hui-Yu Huang, Michael W. Greene
    PLOS ONE.2021; 16(6): e0251646.     CrossRef
  • Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin
    Indira Purushothaman, Ian S. Zagon, Joseph W. Sassani, Patricia J. McLaughlin
    Biochemical Pharmacology.2021; 192: 114712.     CrossRef
  • Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
    Daiji Kawanami, Yuichi Takashi, Yoshimi Muta, Naoki Oda, Dai Nagata, Hiroyuki Takahashi, Makito Tanabe
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Effects of single and dual RAAS blockade therapy on progressive kidney disease transition to CKD in rats
    Devesh Aggarwal, Gaaminepreet Singh
    Naunyn-Schmiedeberg's Archives of Pharmacology.2020; 393(4): 615.     CrossRef
  • Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model
    Shih-Chun Yang, Ching-Yun Hsu, Wei-Ling Chou, Jia-You Fang, Shih-Yi Chuang
    Molecules.2020; 25(23): 5713.     CrossRef
  • Losartan improves renal function and pathology in obese ZSF-1 rats
    Zhi Su, Deborah Widomski, Arthur Nikkel, Laura Leys, Marian Namovic, Diana Donnelly-Roberts, Murali Gopalakrishnan, Steve McGaraughty
    Journal of Basic and Clinical Physiology and Pharmacology.2018; 29(3): 281.     CrossRef
  • Analyzing polymeric nanofibrous scaffold performances in diabetic animal models for translational chronic wound healing research
    Nowsheen Goonoo, Archana Bhaw-Luximon
    Nanotechnology Reviews.2017; 6(6): 583.     CrossRef
  • Stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in type 2 diabetes with nephropathy
    Motonobu Nakamura, Nobuhiko Satoh, Masashi Suzuki, Haruki Kume, Yukio Homma, George Seki, Shoko Horita
    Biochemical and Biophysical Research Communications.2015; 461(1): 154.     CrossRef
  • Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats
    Amal Hofni, Mohamed A. El-Moselhy, Ashraf Taye, Mohamed M. Khalifa
    European Journal of Pharmacology.2014; 744: 173.     CrossRef
  • Renal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats
    Jia-sheng Wu, Rong Shi, Jie Zhong, Xiong Lu, Bing-liang Ma, Tian-ming Wang, Bin Zan, Yue-ming Ma, Neng-neng Cheng, Fu-rong Qiu
    Evidence-Based Complementary and Alternative Medicine.2013; 2013: 1.     CrossRef
  • The use of animal models in diabetes research
    Aileen JF King
    British Journal of Pharmacology.2012; 166(3): 877.     CrossRef
  • Effect of Eplerenone, a Selective Aldosterone Blocker, on the Development of Diabetic Nephropathy in Type 2 Diabetic Rats
    Jae Hee Ahn, Ho Cheol Hong, Myong Jin Cho, Yoon Jung Kim, Hae Yoon Choi, Chai Ryoung Eun, Sae Jeong Yang, Hye Jin Yoo, Hee Young Kim, Ji A Seo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Nan Hee Kim
    Diabetes & Metabolism Journal.2012; 36(2): 128.     CrossRef
Review
New Perspectives on Diabetic Vascular Complications: The Loss of Endogenous Protective Factors Induced by Hyperglycemia
In-Kyung Jeong, George L. King
Diabetes Metab J. 2011;35(1):8-11.   Published online February 28, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.1.8
  • 6,207 View
  • 33 Download
  • 24 Crossref
AbstractAbstract PDFPubReader   

Diabetic vascular complications are among the leading causes of morbidity and mortality in diabetic patients. In the past, many studies have focused on the mechanisms of hyperglycemia-induced chronic vascular complications via the formation of toxic metabolites such as oxidative stress, advanced glycosylated end products, persistent activation of protein kinase C, and increased sorbitol concentrations. However, vascular complications result from imbalances caused by increases in systemic toxic metabolites, such as those that occur under conditions of hyperglycemia and dyslipidemia, and by reductions in endogenous protective factors such as insulin, vascular endothelial growth factor, and platelet derived growth factor. This review outlines some of the evidence supporting the importance of enhancing endogenous regenerative factors.

Citations

Citations to this article as recorded by  
  • Role of platelet-derived growth factor c on endothelial dysfunction in cardiovascular diseases
    Adriana Grismaldo, Luis Sobrevia, Ludis Morales
    Biochimica et Biophysica Acta (BBA) - General Subjects.2022; 1866(10): 130188.     CrossRef
  • Ginkgo biloba extracts protect human retinal Müller glial cells from t-BHP induced oxidative damage by activating the AMPK-Nrf2-NQO-1 axis
    Yue Li, Ke Wang, Xue Zhu, Zhengqi Cheng, Ling Zhu, Michael Murray, Fanfan Zhou
    Journal of Pharmacy and Pharmacology.2022;[Epub]     CrossRef
  • Organic Isothiocyanates as Hydrogen Sulfide Donors
    Alma Martelli, Valentina Citi, Lara Testai, Simone Brogi, Vincenzo Calderone
    Antioxidants & Redox Signaling.2020; 32(2): 110.     CrossRef
  • PGC‐1α, a potential therapeutic target against kidney aging
    Gayoung Lee, Md Jamal Uddin, Yoojeong Kim, Minji Ko, Inyoung Yu, Hunjoo Ha
    Aging Cell.2019;[Epub]     CrossRef
  • Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria
    Yongin Cho, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-wan Lee
    Journal of Diabetes and its Complications.2019; 33(8): 585.     CrossRef
  • Ameliorative effects of taurine against diabetes: a review
    Inam-u-llah, Fengyuan Piao, Rana Muhammad Aadil, Raheel Suleman, Kaixin Li, Mengren Zhang, Pingan Wu, Muhammad Shahbaz, Zulfiqar Ahmed
    Amino Acids.2018; 50(5): 487.     CrossRef
  • Notoginsenoside Fc attenuates high glucose-induced vascular endothelial cell injury via upregulation of PPAR-γ in diabetic Sprague–Dawley rats
    Jingjing Liu, Chunyu Jiang, Xu Ma, Jianbo Wang
    Vascular Pharmacology.2018; 109: 27.     CrossRef
  • Grape seed proanthocyanidin extract protects the retina against early diabetic injury by activating the Nrf2 pathway
    YAN SUN, CAIMEI XIU, WEI LIU, YUAN TAO, JIANRONG WANG, YI QU
    Experimental and Therapeutic Medicine.2016; 11(4): 1253.     CrossRef
  • Hydrogen peroxide prevents vascular calcification induced ROS production by regulating Nrf-2 pathway
    Wensong Zhang, Yi Li, Hanlu Ding, Yaqin Du, Li Wang
    Renal Failure.2016; 38(7): 1099.     CrossRef
  • TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes
    Feng Jiang, Qingzhong Chen, Liming Huang, Ying Wang, Zhuhong Zhang, Xiangda Meng, Yuanyuan Liu, Chunjie Mao, Fang Zheng, Jingkai Zhang, Hua Yan
    International Journal of Molecular Sciences.2016; 17(5): 615.     CrossRef
  • Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial
    Sanghoon Shin, Kwang-Joon Kim, In-Jeong Cho, Geu-Ru Hong, Yangsoo Jang, Namsik Chung, Young Min Rah, Hyuk-Jae Chang
    Yonsei Medical Journal.2015; 56(5): 1227.     CrossRef
  • NRF2 plays a protective role in diabetic retinopathy in mice
    Zhenhua Xu, Yanhong Wei, Junsong Gong, Hongkwan Cho, James K. Park, Ee-Rah Sung, Hu Huang, Lijuan Wu, Charles Eberhart, James T. Handa, Yunpeng Du, Timothy S. Kern, Rajesh Thimmulappa, Alistair J. Barber, Shyam Biswal, Elia J. Duh
    Diabetologia.2014; 57(1): 204.     CrossRef
  • Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ‐induced diabetes
    Yucheng Liu, Yonggang Wang, Xiao Miao, Shanshan Zhou, Yi Tan, Guang Liang, Yang Zheng, Quan Liu, Jian Sun, Lu Cai
    Journal of Cellular and Molecular Medicine.2014; 18(6): 1203.     CrossRef
  • Sulforaphane Attenuation of Type 2 Diabetes-Induced Aortic Damage Was Associated with the Upregulation of Nrf2 Expression and Function
    Yonggang Wang, Zhiguo Zhang, Wanqing Sun, Yi Tan, Yucheng Liu, Yang Zheng, Quan Liu, Lu Cai, Jian Sun
    Oxidative Medicine and Cellular Longevity.2014; 2014: 1.     CrossRef
  • Therapeutic Effect of MG132 on the Aortic Oxidative Damage and Inflammatory Response in OVE26 Type 1 Diabetic Mice
    Xiao Miao, Wenpeng Cui, Weixia Sun, Ying Xin, Bo Wang, Yi Tan, Lu Cai, Lining Miao, Yaowen Fu, Guanfang Su, Yuehui Wang
    Oxidative Medicine and Cellular Longevity.2013; 2013: 1.     CrossRef
  • Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes
    Sang Ouk Chin, Jin Kyung Hwang, Sang Youl Rhee, Suk Chon, You-Cheol Hwang, Seungjoon Oh, Kyu Jeung Ahn, Ho Yeon Chung, Jeong-taek Woo, Sung-Woon Kim, Young Seol Kim, Ja-Heon Kang, In-Kyung Jeong
    Diabetes & Metabolism Journal.2013; 37(5): 365.     CrossRef
  • Downregulation of Nrf2 and HO-1 expression contributes to oxidative stress in type 2 diabetes mellitus: A study in Juana Koslay City, San Luis, Argentina
    Susana Siewert, Irma González, Lucas Santillán, Roberto Lucero, Marta S. Ojeda, María S. Gimenez
    Journal of Diabetes Mellitus.2013; 03(02): 71.     CrossRef
  • The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double‐blind, randomized, controlled trial
    S. Shin, K. J. Kim, H. ‐J. Chang, B. ‐W. Lee, W. ‐I. Yang, B. ‐S. Cha, D. Choi
    Diabetes, Obesity and Metabolism.2013; 15(2): 185.     CrossRef
  • Areca nut procyanidins ameliorate streptozocin-induced hyperglycemia by regulating gluconeogenesis
    Pei-Ling Huang, Chin-Wen Chi, Tsung-Yun Liu
    Food and Chemical Toxicology.2013; 55: 137.     CrossRef
  • Serum glycated albumin predicts the progression of carotid arterial atherosclerosis
    Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Atherosclerosis.2012; 225(2): 450.     CrossRef
  • Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants
    Xiao Miao, Yang Bai, Weixia Sun, Wenpeng Cui, Ying Xin, Yuehui Wang, Yi Tan, Lining Miao, Yaowen Fu, Guanfang Su, Lu Cai
    Nutrition & Metabolism.2012;[Epub]     CrossRef
  • Association between EPCs count and rate of coronary revascularization in asymptomatic type 2 diabetic patients
    Hyun Min Kim, Kwang Joon Kim, Jae Hoon Moon, Hye-Jeong Lee, Min Kyung Chae, Hyuk-Jae Chang, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Young Jin Kim, Byung-Wan Lee
    Acta Diabetologica.2012; 49(6): 413.     CrossRef
  • Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes
    Kyoung Soo Kim, Da Hee Oh, Jung Yeon Kim, Bong Gn Lee, Jeong Soon You, Kyung Ja Chang, Hyunju Chung, Myung Chul Yoo, Hyung-In Yang, Ja-Heon Kang, Yoo Chul Hwang, Kue Jeong Ahn, Ho-Yeon Chung, In-Kyung Jeong
    Experimental & Molecular Medicine.2012; 44(11): 665.     CrossRef
  • Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells
    In-Kyung Jeong, Da Hee Oh, Seung-Joon Park, Ja-Heon Kang, Sunshin Kim, Myung-Shik Lee, Myung-Jun Kim, Yoo-Chul Hwang, Kyu Jeong Ahn, Ho-Yeon Chung, Min-Kyung Chae, Hyung-Joon Yoo
    Experimental and Molecular Medicine.2011; 43(12): 684.     CrossRef
Original Articles
Effects of Anti-Vascular Endothelial Growth Factor (VEGF) on Pancreatic Islets in Mouse Model of Type 2 Diabetes Mellitus.
Ji Won Kim, Dong Sik Ham, Heon Seok Park, Yu Bai Ahn, Ki Ho Song, Kun Ho Yoon, Ki Dong Yoo, Myung Jun Kim, In Kyung Jeong, Seung Hyun Ko
Korean Diabetes J. 2009;33(3):185-197.   Published online June 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.3.185
  • 2,289 View
  • 25 Download
AbstractAbstract PDF
BACKGROUND
Vascular endothelial growth factor (VEGF) is associated with the development of diabetic complications. However, it is unknown whether systemic VEGF treatment has any effects on the pancreatic islets in an animal model of type 2 diabetes mellitus. METHODS: Anti-VEGF peptide (synthetic ATWLPPR, VEGF receptor type 2 antagonist) was injected into db/db mice for 12 weeks. We analyzed pancreatic islet morphology and quantified beta-cell mass. Endothelial cell proliferation and the severity of islet fibrosis were also measured. VEGF expression in isolated islets was determined using Western blot analysis. RESULTS: When anti-VEGF was administered, db/db mice exhibited more severe hyperglycemia and associated delayed weight gain than non-treated db/db mice. Pancreas weight and pancreatic beta-cell mass were also significantly decreased in the anti-VEGF-treated group. VEGF and VEGF receptor proteins (types 1 and 2) were expressed in the pancreatic islets, and their expression was significantly increased in the db/db group compared with the db/dm group. However, the elevated VEGF expression was significantly reduced by anti-VEGF treatment compared with the db/db group. The anti-VEGF-treated group had more prominent islet fibrosis and islet destruction than db/db mice. Intra-islet endothelial cell proliferation was also remarkably reduced by the anti-VEGF peptide. CONCLUSION: Inhibition of VEGF action by the VEGF receptor 2 antagonist not only suppressed the proliferation of intra-islet endothelial cells but also accelerated pancreatic islet destruction and aggravated hyperglycemia in a type 2 diabetes mouse model. Therefore, the potential effects of anti-VEGF treatment on pancreatic beta cell damage should be considered.
Vascular Endothelial Growth Factor (VEGF) and Advanced Glycation End Products (AGEs) Overexpression in the Retina and Serum and Lens Opacities of Streptozotocin-induced Diabetic Rats.
Young Sook Kim, Eun Jin Sohn, Chan Sik Kim, Yun Mi Lee, Dong Ho Jung, Nan Hee Kim, Hyun Young Lee, Jung Yeon Kim, Jin Sook Kim
Korean Diabetes J. 2008;32(1):44-52.   Published online February 1, 2008
DOI: https://doi.org/10.4093/kdj.2008.32.1.44
  • 2,076 View
  • 28 Download
AbstractAbstract PDF
BACKGROUND
Vascular Endothelial Growth Factor (VEGF) and Advanced Glycation End products (AGEs) have been implicated in the development of diabetic retinopathy. In this study, we examined the expression of VEGF and AGEs in the retina and serum, apoptosis in the retina, and lens opacities in streptozotocin (STZ)-induced diabetic rats. METHODS: The localization of VEGF and AGEs in the retina of STZ-induced diabetic rats was determined by immunohistochemical analysis, and apoptotic cell death was assessed using the TUNEL assay. In the serum, STZ-induced diabetic rats were assayed for VEGF and AGEs by ELISA. Lenses were also isolated to detect the opacity. RESULTS: Expression of VEGF and accumulation of AGEs were significantly increased in the retinal ganglion cell layers (GCL) and nuclear cell layers (NCL) of STZ-induced diabetic rats compared to normal control rats. In addition to cellular expression, serum VEGF and AGEs levels were also increased significantly in STZ-diabetic rats compared to normal rats (both P < 0.001) and there was a significant correlation between the serum VEGF and AGEs levels (r = 0.504). The lens opaque density of STZ-induced diabetic rats were significantly higher than in normal rats (P < 0.001). CONCLUSIONS: AGEs could be involved in the development of diabetic retinopathy through the induction of VEGF. One could possibly correlate this lens opaque formation with elevation of AGE induced VEGF level. Thus, this study should be considered as a basic research for studying pathology of the retina and lens in diabetic experimental models.
Comparison of Minicircle with Conventional Plasmid for the Non-viral Vascular Endothelial Growth Factor (VEGF) Gene Therapy.
Minjeong Kwon, Soonhee Lee, Heysook Chung, Changshin Yoon, Mikyung Kim, Jeonghyun Park
Korean Diabetes J. 2007;31(6):465-471.   Published online November 1, 2007
DOI: https://doi.org/10.4093/jkda.2007.31.6.465
  • 1,834 View
  • 21 Download
AbstractAbstract PDF
BACKGROUND
Delayed wound healings in diabetic patients are related with the impairment of the expressions of various growth factors. Treatments using growth factors have been attempted on diabetic foot ulcer. VEGF (vascular endothelial growth factor) accelerates neo-angiogenesis on the early phase of the wound healing and exerts chemo-attractive effect for the other growth factors and cytokines. Non-viral gene transfer strategies are attractive tool for the gene therapy due to the safety and the versatility, but the low efficiency has been the serious problem. METHODS: We performed the VEGF gene therapy using reconstructed minicircle MINI-pbetaVEGF DNA with a polymeric carrier, polyethylenimine (PEI, 25 kDa) in HEK293, CHO, and NIH3T3 cell lines, and compared its efficiency with the conventional VEGF plasmid pbetaVEGF. RESULTS: The levels of expressed VEGF were higher in the groups using BPEI (branched PEI) as a gene carrier than naked plasmid transfer in all cell lines (P < 0.05). The minicircle MINI-pbetaVEGF DNA showed much higher VEGF expression than conventional plasmid pbetaVEGF (P < 0.05). CONCLUSION: Minicircle DNA MINI-pbetaVEGF showed much higher transfection efficiency than conventional plasmid pbetaVEGF. It might be used in actual human clinical trial due to its higher efficiency and possible safety for the treatment of diabetic foot ulcer.
Effective Glycemic Control Achieved by the Transplantation of VEGF-Transfected Islets in STZ-induced Diabetic Mice.
Byung Wan Lee, Hee Young Chae, You Ran Ahn, Seung Hoon Oh, Ji Youn Kim, Yun Jae Chung, Sang Young Kim, Kyun Yung Cho, Jae Hoon Chung, Yong Ki Min, Myung Shik Lee, Moon Kyu Lee, Kwang Won Kim
Korean Diabetes J. 2005;29(4):282-294.   Published online July 1, 2005
  • 1,179 View
  • 19 Download
AbstractAbstract PDF
BACKGROUND
Hypoxic damage is one of the major causes of early islet graft failure, and VEGF is known to play a crucial role in revascularization. We tried to evaluate whether the VEGF transgene in an islet graft can increase islet revascularization and; therefore, increase the survival rate of transplanted islets in order to achieve effective glycemic control in diabetic mice models using a non-viral cationic lipid reagent for gene delivery into non- dividing islet cells. METHODS: Human VEGF165 cDNA was transfected into Balb/c mice islets using Effectene, and the vascular neogenesis and glucose levels examined in the recipient syngeneic Balb/c mice. A minimal number of VEGF-transfected islets(100 IEQ/animal) were transplanted into STZ-induced diabetic mice. The recipient mice were classified into three groups: islet transplantation(IT) without intervention(IT-alone group, n=8), IT with an islets transduced rhoJDK-control vector(IT-rhoJDK group, n=8), and IT with an islets transduced rhoJDK-VEGF vector(IT-rhoJDK-VEGF group, n=8). RESULTS: The transfection efficiency was highest with 4microgram/microliter cDNA and 25microliter Effectene(1: 6 weight ratio), with satisfactory cell viability under these conditions. The overproductions of VEGF mRNA and proteins from the conditioned cells were confirmed. A minimal number of the VEGF-transfected islets(100 IEQ/animal) were transplanted into STZ-induced diabetic mice. The control of hyperglycemia in the IT-alone(0/8) and IT-rhoJDK groups(0/8) failed. However, complete abrogation of hyperglycemia and viable islets, and an increased vascularization of the VEGF-transfected grafts were identified in the renal capsules of the IT-rhoJDK-VEGF group(8/8). CONCLUSION: These studies support the utility of VEGF-transfected islet delivery using a cationic lipid reagent to achieve euglycemia with minimal islets via neovascularization.
Effect and Mechanism of Vascular Endothelial Growth Factor on Endothelial Nitric Oxide Synthase Expression in Aortic Endothelial Cells.
Soon Hee Lee, Jung Guk Kim, Joong Yeol Park, Sung Woo Ha, Bo Wan Kim
Korean Diabetes J. 2002;26(5):396-404.   Published online October 1, 2002
  • 867 View
  • 16 Download
AbstractAbstract PDF
BACKGROUND
Vascular endothelial growth factor (VEGF), a soluble angiogenic factor produced by many tumor and normal cells, is a potent angiogenic and vascular permeability factor. VEGF plays a key role in both pathological and physiological angiogenesis. There are many recent findings regarding the role of VEGF in diabetic microvascular and macrovascular diseases. Many approaches with VEGF-related therapies begin to treat and prevent these complications and have been used for the treatment of microvascular complications such as diabetic retinopathy, whereas VEGF agonists have been used to treat macrovascular complications such as myocardial infarction and peripheral limb ischemia. Nitric oxide (NO) is known to mediate many physiological and pathological functions, including modulation of vascular tone, permeability, and capillary growth. Recent reports indicate that NO may play an intimate role in VEGF signaling. Therefore, we hypothesized that the expression of eNOS may be regulated by VEGF. The objectives of the present study were to determine whether VEGF up-regulates the expression of endothelial NO synthase (eNOS) in endothelial cells and to elucidate the mechanism that mediate this response. METHODS: Endothelial cells were isolated from bovine aortae. The expression of eNOS was assessed by Northern blotting analysis. To evaluate the mechanism of VEGF-induced eNOS expression, endothelial cells were conditioned with VEGF and pretreated with phorbol-12-myristate acetate (PMA), a protein kinase C (PKC) activator, or GF109203X (GFX), a PKC inhibitor. The changes of eNOS gene expression. RESULTS: VEGF significantly increased the expression of eNOS mRNA in bovine aortic endothelial cells (BAEC) in time and dose dependent manners. PMA increased the expression of eNOS mRNA, as well as the VEGF-induced expression of eNOS mRNA in endothelial cells, while inhibition of the PKC activity, with the GFX blocked the upregulation of the VEGF-induced eNOS mRNA. CONCLUSION: The results suggest that VEGF upregulates eNOS gene expression in aortic endothelial cells, by a PKC dependent pathway and, eNOS may be important in the development of VEGF-induced angiopathy.

Diabetes Metab J : Diabetes & Metabolism Journal